| 1 | Nanoparticle‐Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy | Angewandte Chemie - International Edition | 2019 | 920 |
| 2 | Nanoscale Metal–Organic Frameworks for Therapeutic, Imaging, and Sensing Applications | Advanced Materials | 2018 | 643 |
| 3 | Current recommendations and recent progress in endometrial cancer | Ca-A Cancer Journal for Clinicians | 2019 | 490 |
| 4 | STING pathway agonism as a cancer therapeutic | Immunological Reviews | 2019 | 300 |
| 5 | Multipotential differentiation of human urine-derived stem cells: Potential for therapeutic applications in urology | Stem Cells | 2013 | 295 |
| 6 | Mutational spectrum in a worldwide study of 29,700 families withBRCA1orBRCA2mutations | Human Mutation | 2018 | 278 |
| 7 | Exploring the emerging role of the microbiome in cancer immunotherapy | | 2019 | 272 |
| 8 | Lactobacillus rhamnosus GG induces cGAS/STING- dependent type I interferon and improves response to immune checkpoint blockade | Gut | 2022 | 246 |
| 9 | Metastasis-Suppressor Genes: a Review and Perspective on an Emerging Field | Journal of the National Cancer Institute | 2000 | 229 |
| 10 | Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000‐patient 15‐year experience | Hepatology | 2018 | 213 |
| 11 | Inactivation of DNA-Dependent Protein Kinase by Protein Kinase Cδ: Implications for Apoptosis | Molecular and Cellular Biology | 1998 | 207 |
| 12 | Sirtuins at the crossroads of stemness, aging, and cancer | Aging Cell | 2017 | 186 |
| 13 | Measuring response in a post-RECIST world: from black and white to shades of grey | Nature Reviews Cancer | 2006 | 177 |
| 14 | A Nanoscale Metal–Organic Framework to Mediate Photodynamic Therapy and Deliver CpG Oligodeoxynucleotides to Enhance Antigen Presentation and Cancer Immunotherapy | Angewandte Chemie - International Edition | 2020 | 177 |
| 15 | A streamlined mass spectrometry–based proteomics workflow for large‐scale FFPE tissue analysis | Journal of Pathology | 2020 | 175 |
| 16 | Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials | Lancet Oncology, The | 2015 | 171 |
| 17 | International Transporter Consortium Commentary on Clinically Important Transporter Polymorphisms | Clinical Pharmacology and Therapeutics | 2013 | 157 |
| 18 | Characterization of the Theorectical Radiation Dose Enhancement from Nanoparticles | Technology in Cancer Research and Treatment | 2007 | 156 |
| 19 | AAPM task group report 302: Surface‐guided radiotherapy | Medical Physics | 2022 | 141 |
| 20 | Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma | | 2021 | 132 |
| 21 | Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation | British Journal of Haematology | 2016 | 131 |
| 22 | Clinical and molecular markers of long‐term survival after oligometastasis‐directed stereotactic body radiotherapy (SBRT) | Cancer | 2016 | 130 |
| 23 | Nanoparticle‐Mediated Radiotherapy Remodels the Tumor Microenvironment to Enhance Antitumor Efficacy | Advanced Materials | 2023 | 130 |
| 24 | 5-Fluorouracil, adriamycin, and mitomycin-C (FAM) chemotherapy for advanced adenocarcinoma of the pancreas | Cancer | 1980 | 119 |
| 25 | Gefitinib response of erlotinib-refractory lung cancer involving meninges—role of EGFR mutation | Nature Clinical Practice Oncology | 2006 | 118 |
| 26 | Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials | Journal of Clinical Oncology | 2023 | 118 |
| 27 | Management of radiotherapy patients with implanted cardiac pacemakers and defibrillators: A Report of the AAPM TG‐203† | Medical Physics | 2019 | 117 |
| 28 | Persistent Pain and Frailty: A Case for Homeostenosis | Journal of the American Geriatrics Society | 2012 | 108 |
| 29 | Severity of COVID-19 in patients with lung cancer: evidence and challenges | | 2021 | 105 |
| 30 | Methylation Status of the Epstein-Barr Virus Major Latent Promoter C in Iatrogenic B Cell Lymphoproliferative Disease | American Journal of Pathology | 1999 | 101 |
| 31 | Report of AAPM Task Group 155: Megavoltage photon beam dosimetry in small fields and non‐equilibrium conditions | Medical Physics | 2021 | 101 |
| 32 | Preserving elemental content in adherent mammalian cells for analysis by synchrotron‐based x‐ray fluorescence microscopy | Journal of Microscopy | 2017 | 100 |
| 33 | An open‐label, single‐arm, phase 2 trial of the polo‐like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer | Cancer | 2014 | 99 |
| 34 | Oligometastatic prostate cancer: Reality or figment of imagination? | Cancer | 2019 | 91 |
| 35 | Tumour necrosis factor-α inhibition can stabilize disease in progressive vitiligo | British Journal of Dermatology | 2015 | 89 |
| 36 | Metformin for primary colorectal cancer prevention in patients with diabetes: A case‐control study in a US population | Cancer | 2015 | 89 |
| 37 | Swallowing and Tongue Function Following Treatment for Oral and Oropharyngeal Cancer | Journal of Speech, Language, and Hearing Research | 2018 | 87 |
| 38 | Gal9/Tim-3 expression level is higher in AML patients who fail chemotherapy | | 2019 | 87 |
| 39 | Silent cerebral infarction, income, and grade retention among students with sickle cell anemia | American Journal of Hematology | 2014 | 85 |
| 40 | Long non‐coding RNA (lncRNA) H19 induces hepatic steatosis through activating MLXIPL and mTORC1 networks in hepatocytes | Journal of Cellular and Molecular Medicine | 2020 | 83 |
| 41 | FAK Is required for c‐Met/β‐catenin‐driven hepatocarcinogenesis | Hepatology | 2015 | 82 |
| 42 | Mechanisms of ibrutinib resistance in chronic lymphocytic leukaemia and non‐Hodgkin lymphoma | British Journal of Haematology | 2015 | 81 |
| 43 | Prognostic factors in advanced head and neck cancer patients undergoing multimodality therapy | Otolaryngology - Head and Neck Surgery | 1991 | 79 |
| 44 | ELL-associated factor 2 (EAF2), a functional homolog of EAF1 with alternative ELL binding properties | Blood | 2003 | 79 |
| 45 | Phase 1/2 study of epacadostat in combination with ipilimumab in patients with unresectable or metastatic melanoma | | 2019 | 79 |
| 46 | Dysregulation of protein methyltransferases in human cancer: An emerging target class for anticancer therapy | Cancer Science | 2016 | 77 |
| 47 | Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: A report from the Children's Oncology Group | Cancer | 2013 | 76 |
| 48 | Nudges or mandates? The ethics of mandatory flu vaccination | Vaccine | 2015 | 76 |
| 49 | Cross‐talk between EGF and BMP9 signalling pathways regulates the osteogenic differentiation of mesenchymal stem cells | Journal of Cellular and Molecular Medicine | 2013 | 73 |
| 50 | Influence of tumor mutational burden, inflammatory gene expression profile, and PD-L1 expression on response to pembrolizumab in head and neck squamous cell carcinoma | | 2022 | 73 |
